Michele P Lambert, MD, MTR
Associate Professor of Pediatrics (Hematology) at the Children's Hospital of Philadelphia
Attending Physician, Division of Hematology, Children's Hospital of Philadelphia
Consulting Attending Physician, Section of Hematology/Oncology, Pennsylvania Hospital
Consulting Physician, Section of Newborn Pediatrics, Hospital of the University of Pennsylvania
Medical Director, Special Coagulation Laboratory, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia
Co-Director, Frontier Program in Immune Dysregulation, Children's Hospital of Philadelphia
Director, Pediatric Platelet Disorder Program, Division of Hematology, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of Hematology
3615 Civic Center Blvd
Philadelphia, PA 19083
Division of Hematology
3615 Civic Center Blvd
Philadelphia, PA 19083
Office: 215-590-4667
Fax: 267-426-5476
Lab: 215-590-1971
Fax: 267-426-5476
Lab: 215-590-1971
Email:
lambertm@email.chop.edu
lambertm@email.chop.edu
Education:
BS (Biology)
Rensselaer Polytechnic Institute, 1995.
MD
UMDNJ - New Jersey Medical School, 1999.
MTR (Translational Research)
University of Pennsylvania School of Medicine, 2010.
Permanent linkBS (Biology)
Rensselaer Polytechnic Institute, 1995.
MD
UMDNJ - New Jersey Medical School, 1999.
MTR (Translational Research)
University of Pennsylvania School of Medicine, 2010.
Selected Publications
Hillier K, Zobeck M, MacMath D, Chumsky J, Kirk SE, O'Farrell C, Lucari B, Ngwerume F, Gaerlan S, Konde P, Wang KG, Lambert MP, Grace RF, Grimes AB, Kim TO.: Predicting Development of Pediatric Chronic Immune Thrombocytopenia at Disease Onset Using a Statistical Risk Model. Blood Feb 2026.Kim TO, Hillier K, Gunn E, Badawy SM, Grimes AB, Gilbert M, Remiker A, Lilla SAF, Kaicker S, Lambert MP, Grace RF, Terrell DR.: Pediatric Evans Syndrome Diagnostic Evaluation Patterns: Survey Results From the Pediatric ITP Consortium of North America. Pediatr Blood Cancer Jan 2026.
Harris EM, Montcrieff C, O'Farrell C, Konde P, Lambert MP, Grimes AB, Grace RF.: Real-World Use of Avatrombopag in Children and Adolescents With Immune Thrombocytopenia. Pediatr Blood Cancer 2026.
Harris EM, Pincez T, Hillier K, Ting Y-L, DiRaimo J, Helber H, o'Farrell C, Lecluze E, Kim T, Grace RF, Scheurer M, Hale R, Shimano K, Nugent D, Neufeld EJ, Platt C, Lambert MP, Grimes A, Kaicker S.: Germline Genetic Testing Uncovers a High Frequency of Inborn Error of Immunity Diagnoses in Children with Single and Multi-Lineage Immune Cytopenias in a Large U.S. Cohort. American Society of Hematology Annual Meeting, Orlando, FL December 2025.
Doshi BS, Thompson EN, Faig W, Wax A, Obstfeld AE, Lambert MP.: Diagnosis of platelet dysfunction in children: clinical predictors and test methods. Blood Vessel Thromb Hemost 3: 100135, Dec 2025.
Lozano ML, Lambert MP, Al-Samkari H.: Avatrombopag in immune thrombocytopenia and beyond: Current evidence and emerging perspectives. Blood Rev Dec 2025.
Lambert MP, Cooper N, Izquierdo CP, Lucchini E, Audia S, Wang H, Miyakawa Y, Foster MC, Rodriguez MB, Daak A, Kuter DJ: Reproductive health in patients with primary immune thrombocytopenia (ITP) receiving rilzabrutinib: A subgroup analysis from the Phase 3 LUNA3 multicenter study. American Society of Hematology Annual Meeting, Orlando, FL December 2025.
Ross M, Phillips L, Pierce K, Charland D, El Haouzi N, Konde P, Mueler M, Montcrief C, Ukropina S, Wang K, Grace RF, Klaassen RJ, Lambert MP, Remiker A, Hillier K.: Treatment strategies and outcomes in pediatric patients with immune thrombocytopenia (ITP) undergoing surgical procedures: A multicenter study. American Society of Hematology Annual Meeting, Orlando, FL December 2025.
Shimano KA, Grimes AB, Rose MJ, Kaicker S, Shah SJ, Briones M, Gunne E, Nakano TA, Lebensburger JD, Lambert MP, Fritch-Lilla SA, Jesudas R, Lee-Miller CA, Thompson AT, Kochhar M, Crary SE, Hege K, Rothman JA, Ford JB, Bies JJ, Wynn TT, Hsieh L, Ruiz ME, Dinu B, Wong JMW, Kao P-C, Arnold SD, Bennet CM, Despotovic J, Klaassen RJ, Neufeld EJ, Neuner CE, London WB, Grace RF : End-of-study results from the ICON3 pines trial, a phase 3, randomized trial of eltrombopag vs. standard first-line treatment for newly diagnosed immune thrombocytopenia in children. American Society of Hematology Annual Meeting, Orlando, FL December 2025.
Brakhane M, Abbonante V, Laranjieira A, DiBuduo C, Sadler B, Ashworth K, Kong T, Letson C, He F, Fulbright M, Siner J, Chen D, Clemens R, Pegoraro E, Lambert MP, Gollomp K, DiPaola J, Balduini A, Oh S: Activating STIM1 mutations drive the development of myelofibrosis. American Society of Hematology Annual Meeting, Orlando, FL December 2025.